艾克索夫特公司在上海患者身上进行脑植入试验, Axoft tests brain implant in Shanghai patient, expanding into China's neurotech market.

美国创业公司Axoft成功在上海的一名患者身上测试了其脑部植入物, 这标志着它进入中国神经技术市场的里程碑. A U.S. startup, Axoft, has successfully tested its brain implant in a patient in Shanghai, marking a milestone in its expansion into China’s neurotech market. 这一发展突显了脑机接口技术的全球竞争日益激烈,同时也强调外国科技公司在中国面临复杂的地缘政治和监管挑战. This development highlights the growing global competition in brain-computer interface technology while underscoring the complex geopolitical and regulatory challenges foreign tech firms face in China.